LP-0155
- Generic Name
- LP-0155
Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis
Phase 1
Completed
- Conditions
- Psoriasis Vulgaris
- Interventions
- Drug: LEO 134310 vehicle
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 13
- Registration Number
- NCT03669757
- Locations
- 🇩🇪
Investigational Site, Hamburg, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath